Addonizio, G. & Susman, U. (1991) Neuroleptic Malignant Syndrome: A Clinical Approach, pp. 7–10. St Louis, MD: Mosby-Year Book Inc.
Burgoyne, R. W., Acosta, F. X. & Yamamoto, J. (1983) Telephone prompting to increase attendance at a psychiatric outpatient clinic. American Journal of Psychiatry, 140, 345–347.
Carpenter, W. T., Hanlon, T. E., Heinrichs, D. W., et al. (1990) Continuous versus targeted medication in schizophrenic outpatients: outcome results. American Journal of Psychiatry, 147, 1138–1148.
Davis, J. M., Metalon, L., Watanabe, M. D., et al (1994) Depot antipsychotic drugs – place in therapy. Drugs, 47, 741–773.
Dencker, S. J. & Axelsson, R. (1996) Optimising the use of depot antipsychotics. CMS Drugs, 6, 367–381.
Denham, J. & Adamson, L. (1973) The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenia patients. Acta Psychiatrica Scandinavica, 47, 420–430.
Devito, R. A., Brink, L., Sloan, C., et al (1978) Fluphenazine decanoate vs oral antipsychotics: a comparison of their effectiveness in the treatment of schizophrenia as measured by a reduction in hospital read missions. Journal of Clinical Psychiatry, 39, 26–34.
Ershefsky, L., Saklad, S. R., Jann, M.W., et al (1990) Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen. Psychopharmacology Bulletin, 26, 108–114.
Falloon, R. H. (1984) Developing and maintaining adherence to long-term drug-taking regimens. Schizophrenia Bulletin, 10, 412–417.
Freeman, H. (1980) Twelve years' experience with the total use of depot neuroleptics in a defined population. Advances in Biochemical Psychopharmacology, 24, 559–554.
Gerlach, J. (1995) Depot neuroleptics in relapse prevention: advantages and disadvantages. International Journal of Clinical Psychopharmacology Research, 9 (Suppl. 5), 17–20.
Gerlach, J. & Larsen, E. B. (1999) Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatrica Scandinavica Supplementum, 395, 113–117.
Glazer, W. M. & Ereshefsky, L. (1996) A pharmacoeconomic model of outpatient antipsychotic therapy in “revolving door” schizophrenia patients. Journal of Clinical Psychiatry, 57, 337–345.
Gottfires, C. G. & Green, L. (1974) Flupenthixol decanoate in treatment of outpatients. Acta Psychiatrica Scandinavica, 255, 15–24.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology.
Washington DC: US Department of Health, Education and Welfare.
Heyscue, E. H., Levin, G. M. & Merrick, J. P. (1998) Compliance with depot antipsychotic medication by patients attending outpatient clinics. Psychiatric Services, 49, 1232–1234.
Hulka, B. S., Cassel, J., Kupper, L., et al (1976) Communication, compliance and concordance between physicians and patients with prescribed medications. American Journal of Public Health, 66, 847–853.
Kane, J. M. & Kissling, W. (1991) Guidelines for Neuroleptic Relapse Prevention in Schizophrenia.
Marriott, P. & Hiep, A. (1976) A mirror image outpatient study at a depot phenothiazine clinic. Australian and New Zealand Journal of Pyschiatry, 10, 163.
National Institute of Mental Health Psychopharmacology Service Centre Study Group (1964) Phenothiazine treatment in schizophrenia. Archives of General Psychiatry, 10, 246–261.
Rifkin, A., Quitkin, F., Rabiner, C. J., et al (1997) Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year. Archives of General Psychiatry, 34, 43–47.
Schooler, N. R., Levine, J., Severe, J. B., et al (1980) Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate. Archives of General Psychiatry, 37, 16–24.
Tegeler, J. & Lehmann, E. (1981) A follow-up study of shizophrenic outpatients treated with depot antipsychotics. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 5, 79–90.
Turner, A. J. & Vernon, J. C. (1976) Prompts to increase attendance in a community mental health center. Journal of Applied Behavior Analysis, 9, 141–145.
Walburn, J., Gray, R., Gournay, K., et al (2001) Systematic review of patient and nurse attitudes to depot antipsychotic medication. British Journal of Psychiatry, 179, 300–307.